ArticleMolecular cancer therapeutics2017

Bypassing Drug Resistance Mechanisms of Prostate Cancer with Small Molecules that Target Androgen Receptor-Chromatin Interactions.

Kush Dalal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.